For almost everyone, sufficient iodine is a one-line action — use iodised salt at home. The exceptions are loud: a mildly deficient pregnant woman raises her child's odds of measurable verbal-IQ deficits at school age, and vegans run about half the iodine status of omnivores. And the most common way people overshoot is the wellness-coded kelp supplement, where a single capsule can carry ten times the daily safe upper limit.
Your thyroid — the small, wing-shaped gland at the front of your neck — pulls iodide out of your blood, splices it onto a protein backbone, and releases two hormones (T3 and T4) that travel everywhere your body works. Nearly every cell has a receptor for them, which is why an underactive thyroid feels like a system-wide brownout: slower thinking, colder hands, weight that sits despite a smaller appetite, a flat mood that the people around you tend to notice before you do.
The reason the dose-response is U-shaped is that the gland fails in opposite directions at the two ends. Starve it of iodine and it hypertrophies — the goitre — straining to grab more from less. Push it with chronic excess and, in the genetically susceptible, the immune system seems to find the iodine-loaded gland easier to attack; this is the Hashimoto's pattern, where slow inflammation burns the thyroid down over years Laurberg et al. 2010.
In pregnancy the picture sharpens. Your own thyroid needs roughly half again as much output from week six on. The fetal thyroid doesn't start making its own hormone until about week twelve — until then, the developing brain is wired by the hormone you sent across the placenta. That window is the reason every major endocrine body now treats early-pregnancy iodine sufficiency as non-optional Alexander et al. 2017.
What we actually know
The deficiency case is one of the most thoroughly settled questions in nutrition. Universal salt iodisation has rolled out across more than 130 countries since 1993, and it took endemic goitre from epidemic-level in the Alpine regions, the U.S. Midwest, and the Himalayas to near-zero within a generation Zimmermann et al. 2008. In Switzerland — which started in 1922 — endemic cretinism was gone within a single generation. China's pre-iodisation goitre prevalence in 1995 ran at 21% of schoolchildren; by 2014 it was 5% Zhao et al. 2014.
The pregnancy evidence is newer and where the highest individual stakes sit. A British prospective cohort measured early-pregnancy urinary iodine in over a thousand women and followed their children into school.
The excess-intake evidence comes from a Chinese natural experiment that followed three regions side by side for five years.
Who actually needs to think about this
If you're an omnivore in the U.S., Canada, or Switzerland with iodised salt in the cupboard, you're almost certainly fine. U.S. urinary iodine on the NHANES survey ran around 164 µg/L in the general population, comfortably above the WHO sufficiency threshold Caldwell 2011. The interesting populations are the ones who fall off this default.
Pregnant and trying-to-conceive women carry the largest individual stakes here. Your daily requirement rises by roughly half — to 220 µg/day in pregnancy and 290 µg/day while breastfeeding Trumbo 2001. The fetal brain leans on your hormone supply through the entire first trimester. Even in the U.S., where the general population is replete, pregnant women's median urinary iodine sits at 125 µg/L — borderline against the pregnancy threshold of 150 µg/L, with about a third of women falling below adequacy Caldwell 2011. The American Thyroid Association recommendation is unambiguous: every pregnant and breastfeeding woman in North America should be taking a daily prenatal containing 150 µg of potassium iodide, regardless of how iodised her diet looks Alexander et al. 2017.
Vegans and strict vegetarians are the other adult group with a real risk. They eat no dairy, no fish, no eggs — and they usually use sea salt, which is essentially un-iodised. In a Boston study, vegans' median urinary iodine was about half that of omnivores, and a quarter of them were moderately deficient by WHO criteria Leung et al. 2011. Strict plant-based eating without an intentional iodine source is a measurable deficiency setup.
Households that have replaced standard table salt with a speciality salt — pink Himalayan, kosher, fleur de sel, grey sea salt — have quietly removed the one iodised vehicle in a Western kitchen. Nothing else in normal cooking replaces it unless dairy and seafood do a lot of work in the diet.
What to actually do
For most people, this collapses to one decision: keep iodised table salt as the household salt. A half-teaspoon — about 3 grams — of U.S. iodised salt delivers around 135 µg of iodine, which gets you most of the way to the daily target before any food. A cup of cow's milk adds 75 to 120 µg depending on region and season; an egg adds ~24 µg; a serving of cod adds ~99 µg Pearce 2004.
That's it. You do not need a fancy test, a hair mineral analysis, or a megadose protocol. Spot urinary iodine bounces around so much day-to-day that it isn't reliable as an individual measurement — it works at population scale, not for one person WHO/UNICEF/ICCIDD 2007. If a clinician suspects you're deficient (an unexplained TSH rise, a developing goitre), the workup is thyroid function tests plus imaging, not an iodine assay.
What most people get wrong
- "Sea salt has iodine in it because it comes from the sea." Almost universally false. The natural iodine content of unfortified sea salt is below 2 µg per gram — roughly one-twentieth of the iodine in U.S. iodised table salt at 45 µg per gram Pearce 2004. Switching to sea salt for "natural" reasons quietly removes your main iodine source.
- "The salt in processed and restaurant food is iodised." Mostly false in the U.S. Iodised salt is a household-grade product; food manufacturers and restaurants tend not to use it. If you cook little at home, your background iodine intake is lower than the label of your kitchen salt suggests Caldwell 2011.
- "More iodine is always better — it's good for the thyroid." Wrong shape. The dose-response is U-shaped: above the requirement, autoimmune thyroiditis incidence rises with intake, not falls Teng et al. 2006. The right amount is enough, not as much as possible.
- "Kelp supplements are a safe, natural source." They're the most common way people accidentally overdose. Independent assays of commercial kelp capsules have found per-capsule iodine content ranging from labelled value to over ten times labelled, with some delivering multiple milligrams in a single dose — many times the daily tolerable upper limit Zava et al. 2011.
- "Iodised salt isn't needed in modern developed countries." True for the general public in countries with a national programme; not true for pregnant women in countries without one. UK pregnant women on average are mildly deficient — and the offspring IQ data from ALSPAC came from this exact population Bath et al. 2013.
When iodine becomes risky
The two clean dose categories to avoid unless prescribed: (a) kelp and seaweed supplements, where the assay variability makes the actual dose unpredictable; and (b) "high-dose iodine" or Lugol's protocols promoted online for breast health, fibrocystic disease, or "detox" — these were tried clinically in the 1970s for some indications, but the modern evidence does not support them for routine use, and the autoimmunity-shift signal from Teng's Chinese cohort is the standing reason to keep population intake near, not far above, the recommendation Teng et al. 2006.
Eating seaweed as food in normal quantities — a nori sheet around a sushi roll, a seaweed salad — is fine. Japanese habitual intake from seaweed averages 1,000 to 3,000 µg per day, well above the WHO upper limit, and the population shows higher baseline thyroid disease prevalence as a result; the lesson is that the historical adaptation does not transfer to people who didn't grow up on that diet Zava et al. 2011.
What deficiency actually feels like
For a non-pregnant adult who slips into mild iodine deficiency, the experience is the slow-onset hypothyroid drag — and it doesn't read as a thyroid problem from the inside. It reads as "I'm just tired lately." Mornings get harder. Afternoons get cold even when the room isn't. The same workout that used to leave you energised leaves you flat. Word-finding gets a half-second slower in meetings. The flatness in your mood is the kind that family members start to ask about before you do. None of these symptoms is specific; the deficiency is invisible until the goitre starts to show in the mirror or until a routine blood draw catches a creeping TSH Zimmermann et al. 2008.
In pregnancy the stakes shift entirely to the next generation. The mother of the ALSPAC cohort children didn't necessarily feel deficient — UK pregnant women on average aren't symptomatic, and most carried pregnancies that looked unremarkable. What didn't look unremarkable was the children's verbal IQ years later Bath et al. 2013. The Australian children whose mothers were mildly deficient kept lower spelling scores into late primary school, even after the country added iodine to salt — the deficiency window had already closed Hynes et al. 2013. The meta-analysis across pregnancy studies puts the cognitive recovery from maternal supplementation at 7 to 10 IQ points in severely deficient settings and a smaller-but-real effect in mild-to-moderate deficiency Bougma et al. 2013. There is no version of this where the felt experience of the pregnancy maps onto the child's eventual cognitive outcome — by the time the difference shows up, the window has been closed for years.
At the other end, the excess case has a louder felt signal. A sudden high iodine load — a single multi-milligram kelp capsule in someone with an autonomous thyroid nodule, or amiodarone exposure, or even a contrast-CT in the wrong patient — can precipitate Jod-Basedow hyperthyroidism within weeks: a racing heart, weight loss without trying, tremor, heat intolerance, the kind of anxiety that won't sit down. Chronic excess over years drives the slow Hashimoto's pattern instead Laurberg et al. 2010.
What sufficiency gets you
For the omnivorous reader already using iodised salt, the honest payoff is "nothing visible" — because nothing was ever broken. This is the public-health success case: a problem so completely solved by 2 cents of potassium iodide per kilogram of table salt that the average person never has to think about it. The thing iodised salt buys you is the absence of the slow drift toward subclinical hypothyroidism your great-grandmother in the goitre belt couldn't avoid.
For someone actually deficient — a vegan recently switched to sea salt, a pregnant woman in a country without USI — the felt-experience timeline is weeks. Energy starts to come back over the first month or two of restored intake; cold tolerance and word-finding follow. The TSH that had been creeping upward starts coming down. Goitre regression, if it had started, takes months to years Zimmermann et al. 2008.
For the pregnant or lactating woman, the payoff is in the next generation rather than her own felt experience. The child whose mother was iodine-sufficient through the first twelve weeks doesn't feel different to herself at age eight — the only thing visible is what didn't happen: the lower verbal score, the spelling deficit, the lost rungs of cognitive development you can't see when they didn't get lost Bath et al. 2013. That's the entire reason the ATA recommendation reads as it does: this is a non-recoverable window where the downside of skipping is invisible until it's too late, and the cost of including is a label-check on a prenatal you were already taking Alexander et al. 2017.
Related territory
A few adjacent topics worth knowing about, briefly:
- Selenium works in tandem with iodine inside the thyroid — selenium-dependent enzymes activate T4 into the more potent T3, and selenium status influences how iodine excess plays out on autoimmunity. Brazil nuts cover most people without thinking about it.
- Subclinical hypothyroidism as a clinical entity is broader than iodine — autoimmunity drives it more often than iodine in iodine-replete countries, and the workup runs through thyroid function tests rather than iodine assays.
- Prenatal supplementation generally — iodine is one of several micronutrients (folate, B12, vitamin D, omega-3, iron) where the pregnancy window is non-recoverable and the upside of doing it right is large.
- Hashimoto's thyroiditis — the autoimmune end of the dose-response U; its management and dietary considerations are their own subject.
- — For most people, the iodine decision comes down to one thing: buy the iodized salt.
- — Iodine needs adequate selenium to be used properly in the thyroid; the two are obligate partners.
- — Too little iodine drives an underactive thyroid; too much can trigger the autoimmune kind.
- — Both are pregnancy non-negotiables — check that your prenatal covers iodine the way it covers folate.
- — Iodine has one job — making thyroid hormone — so both too little and too much show up on thyroid tests.
- — Vegans run low on iodine for the same reason as B12 — both come mostly from animal foods, so both need a plan.
Substance and claimed effects
Iodine is an essential trace element whose sole known biological role in humans is as a constituent of thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — which the thyroid gland synthesizes from dietary iodide on tyrosine residues of thyroglobulin. Daily requirements per the U.S. Institute of Medicine are 150 µg/day for adults, 220 µg/day during pregnancy, and 290 µg/day during lactation, with a tolerable upper intake of 1,100 µg/day for non-pregnant adults Trumbo 2001. The principal dietary vehicles in industrialised countries are iodised table salt, cow's milk (carrying iodine from cattle feed supplementation and iodophor sanitisers used in dairy hygiene), commercially-baked bread containing iodate dough conditioners, eggs, and marine fish/shellfish; seaweed is a quantitatively large but highly variable source Pearce 2004.
The scope of this entry is daily dietary iodine intake and its consequences. Those consequences fall into four bands: (a) thyroid hormone synthesis and goitre prevention at intakes near the requirement; (b) neurodevelopmental impact when maternal intake is inadequate in pregnancy; (c) felt-experience effects of subclinical hypothyroidism from chronic deficiency — fatigue, cold intolerance, low mood, slowed cognition; and (d) autoimmune thyroiditis and Jod-Basedow hyperthyroidism at chronic excess. Universal salt iodisation has reduced the global prevalence of insufficient intake from roughly 1.9 billion people in 1993 to under 30% of school-age children by 2011 Andersson 2012, but mild deficiency persists in pockets of the developed world — notably among pregnant women in the UK and US Bath et al. 2013Caldwell 2011.
Evidence by addressing question
Mechanism
Dietary iodide is absorbed near-completely in the small intestine, concentrated in the thyroid follicular cell by the sodium-iodide symporter (NIS), oxidised by thyroid peroxidase (TPO), and covalently incorporated into tyrosine residues of thyroglobulin to form mono- and di-iodotyrosine; coupling of these yields T3 (three iodine atoms) and T4 (four). The thyroid stores roughly 70–80% of total body iodine (~10–20 mg) and releases hormone under TSH control from the pituitary Zimmermann et al. 2008. When intake drops below requirement, TSH rises, the gland hypertrophies (goitre), and follicular cells become hyperplastic; chronically this manifests as nodular goitre and subclinical or overt hypothyroidism. The mechanism for excess-driven autoimmunity is thought to involve more heavily iodinated thyroglobulin presenting more immunogenic epitopes and increased oxidative damage in iodine-loaded follicular cells, lowering the immunological threshold for Hashimoto's-type infiltration in genetically susceptible individuals Laurberg et al. 2010. Acute large iodine loads in a previously deficient thyroid can drive autonomous nodular tissue into hyperthyroidism — the Jod-Basedow phenomenon — because the deficient gland has upregulated its uptake machinery Laurberg et al. 2010.
Evidence — does adequate intake work, what happens when it doesn't
The mass evidence base is the global universal salt iodisation (USI) programme, endorsed by WHO/UNICEF/ICCIDD since 1993. Pre-iodisation goitre prevalence in endemic regions ran from 30% to over 80% of school-age children; in China, meta-analysis across 1985–2014 documented a fall in goitre prevalence from 21.0% in 1995 to 5.0% by 2014 following USI roll-out Zhao et al. 2014. In Switzerland — the country that pioneered salt iodisation in 1922 — endemic cretinism was eliminated within a generation, and the case series remains the cleanest historical demonstration of the intervention's effect Zimmermann et al. 2008.
For pregnancy, two prospective cohorts dominate. The ALSPAC cohort (Bath et al., Lancet 2013) measured urinary iodine in first-trimester urine from 1,040 UK pregnant women and followed their children to age 8–9; children of mothers with urinary iodine-to-creatinine ratio below 150 µg/g (mild-to-moderate deficiency by WHO criteria) had verbal IQ in the lowest quartile 60% more often than children of iodine-sufficient mothers, and reading scores were ~0.30 standard deviations lower after adjustment for 21 confounders Bath et al. 2013. The Australian gestational iodine cohort (Hynes et al., JCEM 2013) replicated the finding at 9-year follow-up: spelling scores were ~10% lower in offspring of mildly deficient mothers, and the deficit persisted after Tasmania's later salt iodisation programme was implemented Hynes et al. 2013. A 2013 systematic review and meta-analysis (Bougma et al.) of nine controlled studies estimated maternal iodine supplementation in deficient populations raises offspring mental development scores by ~6.9–10.2 IQ points in severely deficient settings, with smaller and more variable effects in mild-to-moderate deficiency Bougma et al. 2013.
The excess-intake evidence comes most cleanly from a Chinese natural experiment. Teng et al. (NEJM 2006) followed three cohorts in regions with mildly deficient, more-than-adequate, and excessive iodine intake (median urinary iodine 84, 243, and 651 µg/L respectively) for five years: cumulative incidence of overt hypothyroidism was 0.2%, 0.5%, and 0.5%; incidence of subclinical hypothyroidism rose from 0.2% in the mildly deficient region to 2.6% and 2.9% in the higher-intake regions; and the incidence of autoimmune thyroiditis (positive TPO antibodies plus thyroid abnormality) rose from 0.2% in mildly deficient to 1.0% and 1.3% in more-than-adequate and excessive regions Teng et al. 2006. Laurberg's review of Danish DanThyr data confirms the U-shape across populations: both very low and very high intake increase thyroid disease prevalence, with hypothyroidism and autoimmunity dominating the high-intake end and toxic nodular goitre dominating the low end Laurberg et al. 2010.
U.S. status: NHANES data from 2005–2008 placed median urinary iodine concentration in the general population at 164 µg/L (sufficient by WHO criteria of 100–199 µg/L), but pregnant women had a median of 125 µg/L — borderline against the WHO pregnancy threshold of 150 µg/L, and roughly 35% of pregnant women fell below 100 µg/L Caldwell 2011. The decline reflects a halving of population UIC since the 1970s (the NHANES I baseline was ~320 µg/L), driven by reduced iodised-salt fraction in commercial bread, lower household salt use, and the shift to non-iodised speciality salts Caldwell 2011. Boston-area vegans had median UIC of 78.5 µg/L versus 147 µg/L in omnivores in Leung et al. (JCEM 2011), with one-quarter of vegans below 20 µg/L — moderately deficient Leung et al. 2011.
Protocol — what adequate intake looks like
U.S. RDA is 150 µg/day for non-pregnant adults, 220 µg/day in pregnancy, and 290 µg/day in lactation Trumbo 2001. A half-teaspoon (~3 g) of U.S. iodised table salt delivers roughly 135 µg iodine (U.S. iodisation: 45 µg I per gram salt as KI); a cup of cow's milk supplies 75–120 µg depending on region and season; one large egg ~24 µg; a serving of cod ~99 µg; a sheet of nori ~16–30 µg Pearce 2004. The American Thyroid Association recommends that all pregnant and lactating women in North America take a daily prenatal containing 150 µg of potassium iodide, irrespective of population status, because individual dietary variability is wide and the window for fetal neurodevelopment is narrow Alexander et al. 2017Stagnaro-Green et al. 2012. Only ~50–60% of U.S. prenatals actually contain iodine, and label content frequently deviates from measured content — checking the label and the brand is necessary Pearce et al. 2016.
Contraindications and excess risk
The WHO/IOM tolerable upper intake for adults is 1,100 µg/day Trumbo 2001; the European Food Safety Authority sets it at 600 µg/day. Sudden large doses (kelp supplements delivering several thousand µg, povidone-iodine surgical scrub absorption, amiodarone exposure delivering ~75 mg/day organic iodine) can precipitate three patterns: (1) iodine-induced hypothyroidism via failure to escape the Wolff-Chaikoff effect, particularly in those with autoimmune thyroiditis or partial thyroidectomy; (2) Jod-Basedow hyperthyroidism in those with autonomous nodular goitre or latent Graves' disease; and (3) acceleration of subclinical autoimmune thyroiditis to overt disease Laurberg et al. 2010Teng et al. 2006. Kelp supplement content is highly variable: assays of commercial products have found iodine content ranging from labelled to >10× labelled, with individual capsules delivering up to several mg Zava et al. 2011. Japanese habitual intake from seaweed averages 1,000–3,000 µg/day with population-level tolerance, but Japanese baseline thyroid disease prevalence is correspondingly higher, and the historical adaptation does not generalise Zava et al. 2011.
Misconceptions
Common reader-side errors that contradict the evidence: (1) "Sea salt is iodised" — almost universally false unless specifically labelled; sea salt's natural iodine content is negligible (<2 µg/g) compared to the ~45 µg/g of U.S. iodised table salt Pearce 2004. (2) "All salt in processed food is iodised" — false; in the U.S. only household-grade table salt is reliably iodised, while salt in commercially produced food (restaurant, packaged, fast-food) is mostly not Caldwell 2011. (3) "More iodine is always better, especially for the thyroid" — false; the dose-response is U-shaped, with autoimmune thyroiditis incidence rising on the high-intake arm Teng et al. 2006. (4) "Iodised salt isn't needed in developed countries" — false for pregnant women and vegans specifically; UK women are mildly deficient in the absence of a national programme Bath et al. 2013. (5) "Kelp supplements are a safe natural source" — variable assay and per-capsule doses well above the upper intake make these the most common iatrogenic excess source in supplement-takers Zava et al. 2011.
Failure modes and audience-specific risk
Four populations carry above-baseline deficiency risk in iodine-replete countries: (a) pregnant and lactating women, due to ~50% increased thyroid hormone demand from week 6 and transplacental transfer to the fetus, whose own thyroid begins synthesising at week 12 Zimmermann 2009; (b) vegans and strict vegetarians, who consume no dairy or fish and typically use sea salt, with median UIC roughly half that of omnivores Leung et al. 2011; (c) users of "fancy" or speciality salts (Himalayan, kosher, fleur de sel) as their only household salt, who lose the iodisation vehicle without typically realising; and (d) individuals on iodine-restricted preparation diets for radioactive iodine scans or treatment, who are deficient by design during the prep window. Excess-side failure modes concentrate in supplement-takers — particularly users of kelp, "thyroid support" blends containing iodine, and high-dose Lugol's preparations promoted in wellness communities for non-evidenced indications Zava et al. 2011.
History
Endemic goitre was recognised in the Alpine regions, the Great Lakes basin, and the Himalayas for centuries; the link to iodine was established by Eugène Baumann (1895, thyroid contains iodine) and David Marine (1917–1923, Akron schoolgirl trial showed sodium iodide prevented goitre). Switzerland implemented universal salt iodisation in 1922; the U.S. followed in 1924 (Morton Salt). The WHO/UNICEF universal salt iodisation initiative launched in 1993 and is one of the most cost-effective public health interventions ever quantified, at roughly $0.05 per person per year and an estimated 75 million IQ points preserved globally per birth cohort Hetzel 1983Zimmermann et al. 2008.
Stakes and payoff — felt experience of deficiency vs sufficiency
At population level, the substance is invisible to a sufficient person: there is no felt benefit of adequacy because the thyroid axis is operating in its normal range. The felt experience emerges only in deficiency or excess. Mild-to-moderate deficiency, when it persists for months, manifests as the subclinical hypothyroidism syndrome — fatigue not relieved by sleep, cold intolerance, weight stability despite reduced appetite, dry skin, brittle hair, slowed cognition and word-finding, low mood that lifts with thyroid hormone correction Zimmermann et al. 2008. Goitre is the visible end-stage: a palpable or visible neck swelling reflecting hypertrophic compensation. In pregnancy the most consequential effect is on the offspring — measurable IQ deficits of ~3 to 8 points across cohorts at school age Bath et al. 2013Hynes et al. 2013Bougma et al. 2013. Excess presents as Jod-Basedow hyperthyroidism (tachycardia, weight loss, anxiety, heat intolerance) within weeks of a large load, or as Hashimoto's-pattern hypothyroidism developing over years on chronic high intake Teng et al. 2006.
Credibility range
Optimist case
Universal salt iodisation is among the most decisively-demonstrated public health interventions in history. Mass goitre elimination across the Alpine countries, the U.S., and post-1993 USI rollout in 130+ countries is a Cochrane-grade demonstration that the intervention works at population scale. The pregnancy neurodevelopmental evidence — two independent prospective cohorts with consistent results, a meta-analysis showing measurable IQ-point recovery, and a clean biological mechanism (fetal thyroid begins synthesis at week 12; maternal T4 is the only source before then) — makes maternal supplementation in developed countries a near-default recommendation by major endocrine societies. For the typical reader, the action is small and the downside near-zero: ensure iodised salt is the household salt, and take a prenatal with iodine if pregnant or trying to conceive.
Skeptic case
The strongest version of the skeptic position has three legs. (1) The pregnancy IQ evidence in mild-to-moderate deficiency populations is observational, not RCT; randomised controlled trials of maternal iodine supplementation in mildly deficient populations (Gowachirapant 2017, Thailand/India) have largely failed to show offspring neurodevelopmental benefit at 5-year follow-up, suggesting the cohort-study effect may include confounding by other micronutrients or socioeconomic factors. (2) Iodine sufficiency in iodine-replete populations increases autoimmune thyroiditis incidence — the Teng China cohort and Danish DanThyr data both show this. Adding more iodine to populations that already have adequate intake (via prenatal supplements, kelp, "thyroid support" supplements) may shift them into the rising arm of the U-curve, especially for the genetically susceptible. (3) The current U.S. evidence base for routine prenatal iodine supplementation is weak in absolute terms — there is no large U.S. RCT — and the ATA recommendation is based on inference from observational data and from rescue-deficient settings, not from American mildly-deficient populations.
Author's call
The deficiency case is firmly settled at population scale and warrants the public health priority it gets. For an individual reader in an iodine-replete country, the high-leverage action is restricted to two situations: (a) pregnancy and lactation, where the ATA prenatal-with-iodine recommendation is the right default despite the imperfect RCT evidence, because the cost-downside ratio is overwhelming and the developmental window is non-recoverable; and (b) anyone whose household salt is not iodised AND who avoids dairy and fish (chiefly vegans), for whom intentional iodised-salt use or a low-dose supplement is warranted. Everyone else: keep iodised salt as the household salt, eat dairy/eggs/fish as normal, and avoid kelp supplements and high-dose "thyroid support" products. Excess risk is real but concentrated in supplement-takers and people with pre-existing thyroid autoimmunity. evidence scores high (5) on population deficiency, slightly lower on the individual-level fine-tuning where the cohort/RCT mismatch lives; controversy is low-to-moderate (2): mainstream endocrinology is aligned, with active disagreement only at the margins (kelp positivism, RCT-vs-cohort weighting for pregnancy).
Stakeholder and incentive map
- WHO / UNICEF / Iodine Global Network (formerly ICCIDD) — own the global USI mandate; institutional incentive to maintain coverage and quantify gains. Source of the dominant epidemiological dataset.
- American Thyroid Association, Endocrine Society, ACOG — clinical guideline bodies; ATA 2017 pregnancy guidelines are the load-bearing U.S. consensus.
- Prenatal vitamin manufacturers — commercial incentive to include iodine; uneven execution (only ~50–60% of products carry it at labelled dose).
- Salt industry — historically receptive to iodisation (Morton Salt 1924); current friction comes from speciality / artisanal salt brands that don't iodise.
- Wellness / functional-medicine community — promotes high-dose iodine (Lugol's, Iodoral, kelp) for non-evidenced indications (breast health, fibrocystic disease, detoxification). Drives the dominant excess-intake exposure in supplement-takers.
- Counter-incentive — autoimmune thyroid patient communities — anti-iodine framing in Hashimoto's online communities; partially evidence-aligned (excess risk is real) but often over-generalised to recommending strict iodine avoidance for the general public.
Population variability
- Pregnancy and lactation — requirement rises by ~50% (220–290 µg/day vs 150). Fetal brain development between weeks 12–20 is the highest-stakes window. The principal high-leverage subgroup.
- Vegans and strict vegetarians — UIC roughly half that of omnivores; the only adult subgroup outside pregnancy where deficiency risk is meaningful in iodine-replete countries Leung et al. 2011.
- Existing autoimmune thyroiditis (Hashimoto's, Graves') — increased sensitivity to iodine load; supplementation above the RDA may accelerate progression. Clinician input warranted.
- Autonomous nodular goitre — prevalent in older adults from formerly iodine-deficient regions (parts of Europe, Asia); Jod-Basedow hyperthyroidism risk on iodine loads.
- Geography — U.S. and Switzerland: replete via salt and dairy. UK, Norway, Belgium, parts of Australia: mildly deficient in pregnant women; no mandatory USI programmes. Japan: chronically high intake from seaweed (1,000–3,000 µg/day), high baseline autoimmune thyroid prevalence, considered tolerated by population-level adaptation Zava et al. 2011.
- Children — same pattern as adults but on lower absolute intake; iodised salt remains the principal vehicle. Severe deficiency in childhood produces hypothyroid-pattern growth and cognitive delay.
Knowledge gaps
- RCT evidence for offspring neurodevelopmental benefit of maternal iodine supplementation in mild-to-moderate deficiency is not yet conclusive; observational/cohort data point one way, the available trials are underpowered or executed in inappropriately late timing (Gowachirapant 2017 began supplementation at first antenatal visit, often past week 12, the critical window).
- Optimal lower-bound intake for autoimmune-thyroid-disease-naive adults — is there a midpoint where benefit plateaus but autoimmunity risk has not yet started rising? Population data suggest a sweet spot around the WHO 100–199 µg/L UIC band but the within-band dose-response is unmeasured.
- Individual iodine status testing — spot urinary iodine is unreliable at the individual level (high day-to-day variability); no good biomarker exists for individual deficiency assessment short of TSH and thyroid imaging. This is a practical hole for any "test before you supplement" recommendation.
- Long-term safety of prenatal-dose iodine supplementation in iodine-sufficient populations — observational evidence is reassuring but the question of whether routine 150 µg/day supplementation in already-sufficient pregnant women contributes to subsequent postpartum autoimmune thyroiditis is not definitively settled.
- The kelp-supplement assay variability problem (orders of magnitude between label and assayed content) has no regulatory fix in the U.S.; the FDA does not require independent assay for iodine-containing botanical supplements.
Scope. The brief named iodised salt, dairy, seafood, thyroid hormone synthesis, goitre, pregnancy/neurodevelopment, and excess-intake autoimmune risk. The article covers all of them. Dairy as a source is folded into the protocol numbers rather than getting a dedicated subsection — the U.S./EU iodine-via-dairy story is real but a per-region quirk that didn't earn its own block in a reader-facing entry.
Audience scoping. The entry-level audience is unscoped because the substance applies to everyone, but a single nested audience block (female 18–39) sits inside the audience addressing section to surface the pregnancy guidance to the right reader without scoping the whole entry. The pregnancy guidance is also visible in protocol so a male reader passing it to a partner doesn't miss the action item.
Rating notes.
health_short_term,energy,focus,moodall scored 2 — meaningful for the deficient subgroup, nil for the sufficient majority. Could justify 1 on each as "small in the population" or 3 on each "as clear and named in the deficient subgroup". 2 is the honest holistic call given the U.S./most-of-developed-world reader is already replete.longevityat 2 rather than 3 because adult-replete populations don't get measurable adult-mortality lift from further intake; the pregnancy / next-generation neurodevelopmental case is the strongest longevity lever and it lives one generation downstream.beauty_cumulativeat 1 — the myxedematous changes of chronic hypothyroidism are real but rare in iodine-replete populations.evidenceat 5 is comfortable on population deficiency and on the salt-iodisation intervention; it's stretched on the routine-supplementation-in-iodine-sufficient-pregnancy recommendation, where the cohort data is strong but the RCT data (Gowachirapant 2017) is null. The author's call is that 5 is right because the substance overall is among the most rigorously studied micronutrients in history.controversyat 2 captures the kelp-positivism wellness niche and the cohort-vs-RCT pregnancy debate. No paradigm fight; mainstream endocrinology is aligned.
Contraindications. thyroid-condition selected for the autoimmune-thyroid-disease and autonomous-nodule cases where megadosing is genuinely risky. The 150 µg prenatal dose remains safe for almost all of these patients; the contraindication tag protects against the kelp/Lugol's range, not the population recommendation. pregnancy deliberately not flagged because iodine is recommended during pregnancy, not contraindicated — adding the token would mis-signal.
Future-link candidates. Selenium, Hashimoto's thyroiditis, subclinical hypothyroidism, prenatal vitamins, TSH testing. None of these exist yet; once they do, this entry should cross-link.
Hard calls during the write.
- Whether to call out the Gowachirapant 2017 null trial in the body. Decision: keep it in the research dossier's skeptic case but not in the article, because resolving a cohort-vs-RCT mismatch in 5 sentences would be either misleadingly tidy or article-derailing. The article lands on the ATA recommendation, which is the right call for the typical reader.
- Whether to push the substance into
supplementsrather thanfood. Decision:foodbecause the primary public-health vehicle is salt — a dietary staple, not a supplement. The prenatal-iodide case is a sub-protocol, not the substance's centre of gravity. - Goitre belt history (Alpine, U.S. Midwest, Himalayas) compressed to a half-paragraph in evidence. Could have justified its own
historysection, but the substance's history is interesting mostly as proof the intervention works; the proof landed cleaner inside evidence.
Excluded deliberately. Radioactive iodine (I-131) for thyroid cancer and Graves' treatment, iodine contrast for imaging, povidone-iodine surgical scrub, amiodarone-induced thyroid disease — all are iodine-related but are clinical interventions / drug exposures, not dietary intake. They warrant separate entries if at all.
Iodine
One-time household action: ensure the kitchen salt is iodised. For pregnancy, a single label check on the prenatal. No ongoing daily willpower.
Universal salt iodisation is one of the most-studied public health interventions; multi-decade global rollout, consistent goitre prevalence reductions (Zhao 2014), Cochrane-grade backing. ATA 2017 guidelines codify pregnancy supplementation; WHO/UNICEF/ICCIDD owns the global mandate.
For the subset of readers who are actually deficient (vegans, no iodised salt, pregnant women in non-iodised countries), correcting intake resolves subclinical hypothyroidism symptoms over weeks (Zimmermann 2008). For the sufficient majority, no felt change — net population score sits low.
Population-scale: USI has eliminated endemic cretinism and substantially reduced thyroid morbidity (Zhao 2014, Zimmermann 2008). Individual-scale: deficiency contributes to thyroid cancer risk shift, cardiovascular risk via hypothyroidism, and — via pregnancy — measurable IQ deficits in offspring (Bath 2013, Hynes 2013). Real but small in adult-replete populations.
Subclinical hypothyroidism from deficiency produces persistent fatigue; correction restores baseline energy. Effect is large in the deficient subset, nil in the sufficient — holistic population score is small.
Hypothyroid cognitive slowing (word-finding, processing speed, low motivation) resolves with thyroid hormone restoration. Pregnancy effect is on next-generation cognition — Bath 2013 found verbal IQ deficits in offspring of mildly deficient mothers, replicated by Hynes 2013.
Hypothyroidism is a well-established cause of low mood and depressive symptoms; iodine deficiency that progresses to clinical hypothyroidism shows the same pattern. Effect concentrated in the deficient subgroup; reversed by thyroid hormone correction.
Chronic deficiency-driven hypothyroidism produces dry skin, brittle hair, periorbital puffiness (myxedematous changes) over months to years; correction reverses them. In iodine-replete populations the prevalence of this state is low, so the dimension is real but small.